Cost-Effectiveness Analysis of Carfilzomib vs Bortezomib in Relapsed/Refractory Multiple Myeloma in Iran

Value in Health Regional Issues · Elsevier

Аннотация

Publication date: May 2027 Source: Value in Health Regional Issues, Volume 59 Author(s): Neshaut Mashreghi Mohammadi, Behzad Fatemi, Mohammad Mahdi Raeis Zadeh, Shekoufeh Nikfar

Читать у издателя →

Похожие статьи